These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 35692496)

  • 1. Development and Validation of a Novel PPAR Signaling Pathway-Related Predictive Model to Predict Prognosis in Breast Cancer.
    Xu Y; Shu D; Shen M; Wu Q; Peng Y; Liu L; Tang Z; Gao S; Wang Y; Liu S
    J Immunol Res; 2022; 2022():9412119. PubMed ID: 35692496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction and Validation of Angiogenesis-Related Prognostic Risk Signature to Facilitate Survival Prediction and Biomarker Excavation of Breast Cancer Patients.
    Xu Y; Peng Y; Shen M; Liu L; Lei J; Gao S; Wang Y; Lan A; Li H; Liu S
    J Oncol; 2022; 2022():1525245. PubMed ID: 35498539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishment of a N1-methyladenosine-related risk signature for breast carcinoma by bioinformatics analysis and experimental validation.
    Li L; Yang W; Jia D; Zheng S; Gao Y; Wang G
    Breast Cancer; 2023 Jul; 30(4):666-684. PubMed ID: 37178414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A seven-nuclear receptor-based prognostic signature in breast cancer.
    Wu F; Chen W; Kang X; Jin L; Bai J; Zhang H; Zhang X
    Clin Transl Oncol; 2021 Jul; 23(7):1292-1303. PubMed ID: 33210236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a Novel Sphingolipid Signaling Pathway-Related Risk Assessment Model to Predict Prognosis in Kidney Renal Clear Cell Carcinoma.
    Sun Y; Xu Y; Che X; Wu G
    Front Cell Dev Biol; 2022; 10():881490. PubMed ID: 35846357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishment of a new prognostic risk model of MAPK pathway-related molecules in kidney renal clear cell carcinoma based on genomes and transcriptomes analysis.
    Zhang P; Li J; Wang Z; Zhao L; Qiu J; Xu Y; Wu G; Xia Q
    Front Oncol; 2023; 13():1077309. PubMed ID: 36969076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrating Bioinformatics and Drug Sensitivity Analyses to Identify Molecular Characteristics Associated with Targeting Necroptosis in Breast Cancer and their Clinical Prognostic Significance.
    Zheng C; Guo H; Mo Y; Liu G
    Recent Pat Anticancer Drug Discov; 2024; 19(5):681-694. PubMed ID: 37653627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and validation of a novel prognostic signature based on transcription factors in breast cancer by bioinformatics analysis.
    Yang Y; Li Z; Zhong Q; Zhao L; Wang Y; Chi H
    Gland Surg; 2022 May; 11(5):892-912. PubMed ID: 35694087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive analysis of suppressor of cytokine signaling proteins in human breast Cancer.
    Sun M; Tang C; Liu J; Jiang W; Yu H; Dong F; Huang C; Rixiati Y
    BMC Cancer; 2021 Jun; 21(1):696. PubMed ID: 34120621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of C-X-C motif chemokine receptors in breast cancer: potential value in immunotherapy and prognostic prediction.
    Sun Y; Yang M; Zhang Q
    Ann Transl Med; 2022 Dec; 10(24):1379. PubMed ID: 36660642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A New Prognostic Risk Model Based on PPAR Pathway-Related Genes in Kidney Renal Clear Cell Carcinoma.
    Xu Y; Li X; Han Y; Wang Z; Han C; Ruan N; Li J; Yu X; Xia Q; Wu G
    PPAR Res; 2020; 2020():6937475. PubMed ID: 33029112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive research into prognostic and immune signatures of transcription factor family in breast cancer.
    Wu Q; Zheng S; Lin N; Xie X
    BMC Med Genomics; 2023 Apr; 16(1):87. PubMed ID: 37098532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Ten-Gene Related to Lipid Metabolism for Predicting Overall Survival of Breast Invasive Carcinoma.
    Wang Z; Wang F
    Contrast Media Mol Imaging; 2022; 2022():8348780. PubMed ID: 35919504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction of a breast cancer prognosis model based on alternative splicing and immune infiltration.
    Zhang D; Lu W; Zhuo Z; Mei H; Wu X; Cui Y
    Discov Oncol; 2022 Aug; 13(1):78. PubMed ID: 35988113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using immune-related lncRNAs to construct novel biomarkers and investigate the immune landscape of breast cancer.
    Qin M; Ma Y; Wang Z; Fang D; Wei J
    Transl Cancer Res; 2021 Jun; 10(6):2991-3003. PubMed ID: 35116607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and validation of a novel zinc finger protein-related gene-based prognostic model for breast cancer.
    Ye M; Li L; Liu D; Wang Q; Zhang Y; Zhang J
    PeerJ; 2021; 9():e12276. PubMed ID: 34721975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Novel Signature Integrated of Immunoglobulin, Glycosylation and Anti-Viral Genes to Predict Prognosis for Breast Cancer.
    Xu S; Liu Y; Ma H; Fang S; Wei S; Li X; Lu Z; Zheng Y; Liu T; Zhu X; Xu D; Pan Y
    Front Genet; 2022; 13():834731. PubMed ID: 35432482
    [No Abstract]   [Full Text] [Related]  

  • 18. Identification of a pyroptosis-related prognostic signature in breast cancer.
    Chen H; Luo H; Wang J; Li J; Jiang Y
    BMC Cancer; 2022 Apr; 22(1):429. PubMed ID: 35443644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of CDK2-Related Immune Forecast Model and ceRNA in Lung Adenocarcinoma, a Pan-Cancer Analysis.
    Liu TT; Li R; Huo C; Li JP; Yao J; Ji XL; Qu YQ
    Front Cell Dev Biol; 2021; 9():682002. PubMed ID: 34409029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive analysis of ICD-related lncRNAs in predicting risk stratification, clinical prognosis and immune response for breast cancer.
    Wang Y; Yue T; He Q
    Aging (Albany NY); 2023 Sep; 15(17):8833-8850. PubMed ID: 37695742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.